BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 9398867)

  • 1. Malignancies in Down syndrome.
    Kusumakumary P; Vats TS; Ankathil R; Gattamaneni HR; Nair MK
    Indian J Pediatr; 1997; 64(6):873-8. PubMed ID: 10771932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome.
    Wang N; Leung J; Warrier RP; Schorin M; Kirkpatrick D; Nowak MJ; Strand R
    Cancer Genet Cytogenet; 1987 Sep; 28(1):155-62. PubMed ID: 2955885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagen sensitivity and cancer susceptibility. Report of a cancer-prone family.
    Liang JC; Pinkel DP; Bailey NM; Trujillo JM
    Cancer; 1989 Oct; 64(7):1474-9. PubMed ID: 2476211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic studies in children with Down syndrome and acute leukemia.
    Valladares A; Palma-Padilla V; Mejía-Aranguré JM; Guevara-Yánez R; Lerma-Reyes A; Salamanca-Gómez F
    Leuk Res; 2005 Nov; 29(11):1241-6. PubMed ID: 16164980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characteristics of Down syndrome newborns.
    Amiel A; Goldzak G; Gaber E; Fejgin MD
    J Hum Genet; 2006; 51(6):541-547. PubMed ID: 16683054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of mutagen-induced chromosome breakage in Down syndrome children with malignancy.
    Ankathil R; Kusumakumary P; Nair MK
    Cancer Genet Cytogenet; 1997 Dec; 99(2):126-8. PubMed ID: 9398867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
    Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
    Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System.
    Satgé D; Seidel MG
    Front Immunol; 2018; 9():3058. PubMed ID: 30631328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of malignant disorders in individuals with Down's syndrome.
    Hasle H
    Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of congenital chromosome abnormalities and malignant diseases].
    Erzsébet B; Andrea N; Róbert S; Eva O
    Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chromosome 21 in hematology and oncology.
    Fonatsch C
    Genes Chromosomes Cancer; 2010 Jun; 49(6):497-508. PubMed ID: 20232485
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.